IP Verse

Glycopeptide Compositions - EP3215173

The patent EP3215173 was granted to Xellia Pharmaceuticals APS on Mar 11, 2020. The application was originally filed on Nov 6, 2015 under application number EP15791287A. The patent is currently recorded with a legal status of "Revoked".

EP3215173

XELLIA PHARMACEUTICALS APS
Application Number
EP15791287A
Filing Date
Nov 6, 2015
Status
Revoked
Jul 15, 2022
Grant Date
Mar 11, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBOct 1, 2020ADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONJPH1180021
DESCRIPTIONUS2014260098
DESCRIPTIONUS4670258
DESCRIPTIONUS8778873
DESCRIPTIONWO2014026052
DESCRIPTIONWO2014085526
DESCRIPTIONWO9719690
INTERNATIONAL-SEARCH-REPORTJP2008201778
INTERNATIONAL-SEARCH-REPORTWO2012159103
INTERNATIONAL-SEARCH-REPORTWO2014194296
INTERNATIONAL-SEARCH-REPORTWO2015138983
OPPOSITIONJP2008201778
OPPOSITIONWO2012159103
OPPOSITIONWO2014194296
OPPOSITIONWO2015138983

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BROWN JP, MOL. PHARMACOL., (1975), vol. 11, pages 126 - 132-
DESCRIPTION- HARRIS CM ET AL., J. ANTIBIOTICS, (1984), vol. 38, no. 1, pages 51 - 57-
DESCRIPTION- KANG; PARK, JOURNAL OF BACTERIOLOGY AND VIROLOGY, (2015), vol. 45, no. 2, pages 67 - 78-
DESCRIPTION- LOLL ET AL., CHEMISTRY AND BIOLOGY, (1998), vol. 5, no. 5-
DESCRIPTION- LOLL ET AL., JOURNAL OF MEDICINAL CHEMISTRY, (1999), vol. 42, no. 22, page 4715-
DESCRIPTION- MCPHAIL; COOPER, J. CHEM. SOC, FARADAY TRANS., (1997), vol. 93, no. 13-
DESCRIPTION- PARENTI; CAVALLERI, JOURNAL OF ANTIBIOTICS, (198912), page 1882-
DESCRIPTION- PEARCE CM ET AL., J. CHEM. SCI. PERKINS TRANS, (1995), vol. 2, pages 159 - 162-
DESCRIPTION- RAO J ET AL., CHEM. & BIOL., (1999), vol. 6, pages 353 - 359-
DESCRIPTION- RAVERDY ET AL., J ANTIMICROB CHEMOTHER, (2013), vol. 68, pages 1179 - 1182-
DESCRIPTION- THE EUROPEAN PHARMACOPEIA 8.0, pages 3525 - 3527-
DESCRIPTION- VAN BAMBEKE, F, CURR. OPIN. INVEST. DRUGS, (2006), vol. 7, no. 8, pages 740 - 749-
DESCRIPTION- WILLIAMS DH ET AL., PROC. NAT. ACAD. SCI. US, (1993), vol. 90, pages 1172 - 1178-
INTERNATIONAL-SEARCH-REPORT- Clive M Pearce ET AL, "Ligands which Bind Weakly t o Vancomycin: Studies by I3C NMR Spectroscopy", J. CHEM. SOC. PERKIN TRANS, (19950101), pages 159 - 163, URL: http://pubs.rsc.org/en/content/articlepdf/1995/P2/P29950000159, (20151207), XP055234260 [YD] 1-143 * abstract * * compounds 6 and 7 *-
OPPOSITION- HARRIS et al., "The stabilization of Vancomycin by peptidoglycan analogs", JOURNAL OF ANTIBIOTICS, (19850000), vol. XXXVIII, no. 1, pages 51 - 57, XP055611981-
OPPOSITION- PEARCE et al., "Ligands which Bind Weakly to Vancomycin: Studies by 13C NMR Spec- troscopy", J. CHEM. SOC. PERKIN TRANS, (19950000), vol. 2, pages 159 - 162, XP055234260-
OPPOSITION- LOLL et al., "A ligand-mediated dimerization mode for vancomycin", Research Paper, Chemistry & Biology, (19980000), vol. 5, no. 5, pages 293 - 298, XP055738691
OPPOSITION- ARRIAGA et al., "Thermodynamic analysis of the interaction of the antibiotic teicoplanin and its aglycone with cell -wall peptides", Biochem. J., (19900000), vol. 265, pages 69 - 77, XP055738700
OPPOSITION- SLAMA et al., "Displacement Study on a Vancomycin-Based Stationary Phase Using N-acetyl-D-Alanine as a Competing Agent", Journal of Chromatographic Science, (20020000), vol. 40, doi:10.1093/chromsci/40.2.83, pages 83 - 86, XP055234137
OPPOSITION- RODRIGUEZ-TEBAR et al., "Thermochemistry of the interaction between peptides and Vancomycin or Ristocetin", THE JOURNAL OF ANTIBIOTICS, (19860000), vol. XXXIX, no. 11, pages 1578 - 1583, XP055738694

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents